PortalPublikationenSummary of the Second Annual BMT CTN Myeloma Intergroup Work...

Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Standard

Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. / Holstein, Sarah A; Ye, J Christine; Howard, Alan; Bhutani, Manisha; Gormley, Nicole; Hahn, Theresa; Hillengass, Jens; Krishnan, Amrita; Landgren, C Ola; Munshi, Nikhil C; Oliva, Stefania; Owen, Roger G; Pasquini, Marcelo C; Puig, Noemi; Weinhold, Niels; Weisel, Katja; McCarthy, Philip L.

in: BIOL BLOOD MARROW TR, Jahrgang 25, Nr. 3, 03.2019, S. e89-e97.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Holstein, SA, Ye, JC, Howard, A, Bhutani, M, Gormley, N, Hahn, T, Hillengass, J, Krishnan, A, Landgren, CO, Munshi, NC, Oliva, S, Owen, RG, Pasquini, MC, Puig, N, Weinhold, N, Weisel, K & McCarthy, PL 2019, 'Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling', BIOL BLOOD MARROW TR, Jg. 25, Nr. 3, S. e89-e97. https://doi.org/10.1016/j.bbmt.2018.11.001

APA

Holstein, S. A., Ye, J. C., Howard, A., Bhutani, M., Gormley, N., Hahn, T., Hillengass, J., Krishnan, A., Landgren, C. O., Munshi, N. C., Oliva, S., Owen, R. G., Pasquini, M. C., Puig, N., Weinhold, N., Weisel, K., & McCarthy, P. L. (2019). Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. BIOL BLOOD MARROW TR, 25(3), e89-e97. https://doi.org/10.1016/j.bbmt.2018.11.001

Vancouver

Holstein SA, Ye JC, Howard A, Bhutani M, Gormley N, Hahn T et al. Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. BIOL BLOOD MARROW TR. 2019 Mär;25(3):e89-e97. https://doi.org/10.1016/j.bbmt.2018.11.001

Bibtex

@article{0f914bee43864beab5f1af358544c1e9,
title = "Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling",
abstract = "The second annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 7, 2017, at the American Society of Hematology (ASH) meeting. During this workshop, investigators from around the world presented their latest research involving assessment of minimal residual disease (MRD) and immune profiling (IP) in myeloma. This document summarizes the workshop presentations as well as relevant ASH abstracts and focuses on the regulatory issues involved in the integration of MRD and IP assessment in clinical trial design and practice.",
keywords = "Journal Article",
author = "Holstein, {Sarah A} and Ye, {J Christine} and Alan Howard and Manisha Bhutani and Nicole Gormley and Theresa Hahn and Jens Hillengass and Amrita Krishnan and Landgren, {C Ola} and Munshi, {Nikhil C} and Stefania Oliva and Owen, {Roger G} and Pasquini, {Marcelo C} and Noemi Puig and Niels Weinhold and Katja Weisel and McCarthy, {Philip L}",
note = "Copyright {\textcopyright} 2018 American Society for Blood and Marrow Transplantation. All rights reserved.",
year = "2019",
month = mar,
doi = "10.1016/j.bbmt.2018.11.001",
language = "English",
volume = "25",
pages = "e89--e97",
journal = "BIOL BLOOD MARROW TR",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

AU - Holstein, Sarah A

AU - Ye, J Christine

AU - Howard, Alan

AU - Bhutani, Manisha

AU - Gormley, Nicole

AU - Hahn, Theresa

AU - Hillengass, Jens

AU - Krishnan, Amrita

AU - Landgren, C Ola

AU - Munshi, Nikhil C

AU - Oliva, Stefania

AU - Owen, Roger G

AU - Pasquini, Marcelo C

AU - Puig, Noemi

AU - Weinhold, Niels

AU - Weisel, Katja

AU - McCarthy, Philip L

N1 - Copyright © 2018 American Society for Blood and Marrow Transplantation. All rights reserved.

PY - 2019/3

Y1 - 2019/3

N2 - The second annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 7, 2017, at the American Society of Hematology (ASH) meeting. During this workshop, investigators from around the world presented their latest research involving assessment of minimal residual disease (MRD) and immune profiling (IP) in myeloma. This document summarizes the workshop presentations as well as relevant ASH abstracts and focuses on the regulatory issues involved in the integration of MRD and IP assessment in clinical trial design and practice.

AB - The second annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 7, 2017, at the American Society of Hematology (ASH) meeting. During this workshop, investigators from around the world presented their latest research involving assessment of minimal residual disease (MRD) and immune profiling (IP) in myeloma. This document summarizes the workshop presentations as well as relevant ASH abstracts and focuses on the regulatory issues involved in the integration of MRD and IP assessment in clinical trial design and practice.

KW - Journal Article

U2 - 10.1016/j.bbmt.2018.11.001

DO - 10.1016/j.bbmt.2018.11.001

M3 - SCORING: Journal article

C2 - 30408566

VL - 25

SP - e89-e97

JO - BIOL BLOOD MARROW TR

JF - BIOL BLOOD MARROW TR

SN - 1083-8791

IS - 3

ER -